Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive Early Breast Cancer

Explore clinical trials studying Hormone Receptor Positive Early Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor Positive Early Breast Cancer trial results

Recruiting

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

NCT07401381

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Early Breast Cancer, +4 more
Locations
  • Precision NextGen Oncology and Research Center (Investigational Site number USA-001) Beverly Hills, California, United States
  • D&H National Research Centers INC (Investigational Site number USA-002) Margate, Florida, United States
  • Investigational Site number SRB-004 Belgrade, Serbia
  • Investigational Site number SRB-002 Belgrade, Serbia
View all 19 locations
View Trial Details

Related conditions